Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Daily Monitor.
Press releases published on September 9, 2025
Global Childhood Academy, Valian and Neue Education Form Strategic Alliance to Transform Early Childhood in the GCC
EIN Presswire
·
September 9, 2025
Global Childhood Academy partners with Valian and Neue Education to scale early childhood education across GCC. RIYADH, RIYADH, SAUDI ARABIA, September 9, 2025 /EINPresswire.com/ -- Global Childhood Academy, Valian and Neue EducationLaunch Strategic …
GARC: Renewed dedication to global rabies elimination efforts
EIN Presswire
·
September 9, 2025
GARC rebrands to renew its mission to end rabies by empowering communities, strengthening capacity, and driving global action. MANHATTAN, KS, UNITED STATES, September 9, 2025 /EINPresswire.com/ -- Since 2007, GARC has been the leading non-profit …
Decisyon Launches AI-Powered Lean Manufacturing Optimizer to Digitalize and Accelerate Shop Floor Innovation
EIN Presswire
·
September 9, 2025
Decisyon’s Lean Manufacturing Optimizer’s embedded AI agents radically improve speed, accuracy …
Primes-maladie 2026 : hausse moyenne de 4% à 5% et de plus de 10% pour certaines caisses
EIN Presswire
·
September 9, 2025
Dans les cas extrêmes, certaines primes pourraient même bondir de plus de 50%. LAUSANNE, VAUD, SWITZERLAND, September 9, 2025 /EINPresswire.com/ -- bonus.ch sur les primes-maladie 2026 : hausse moyenne de 4% à 5% et de plus de 10% pour certaines caisses …
Krankenkassenprämien 2026: Durchschnittliche Erhöhung um 4% bis 5% und um mehr als 10% bei einigen Kassen
EIN Presswire
·
September 9, 2025
In Extremfällen könnten bestimmte Prämien sogar um mehr als 50% in die Höhe schnellen. LAUSANNE, VAUD, SWITZERLAND, September 9, 2025 /EINPresswire.com/ -- bonus.ch zu den Krankenkassenprämien 2026: Durchschnittliche Erhöhung um 4% bis 5% und um mehr …
Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity
GlobeNewswire
·
September 9, 2025
Second Phase 2 trial builds on encouraging initial results from a prior Phase 2 study Aphaia’s formulation activates gastrointestinal nutrient-sensing signaling pathways to modify the course of obesity and associated metabolic diseases ZUG, Switzerland, …
Numab Therapeutics Announces Leadership Transition and Appoints Angehrn Pavik as Chief Executive Officer
GlobeNewswire
·
September 9, 2025
HORGEN, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG (“Numab”), a biotechnology company advancing a proprietary pipeline of multi-specific antibodies in immunology and oncology, today announced that David Urech, Ph.D., Chief …
Adfinanz Completes Conservative, Human-Centric Portfolio Evolution
GlobeNewswire
·
September 9, 2025
Summary: AdFinanz completes strategic evolution emphasizing conservative portfolio elements, strategic independence, and human-centric digital integration. The Geneva-based firm reports 18% higher client retention and a five-year high in satisfaction …